Send us a text

What do you get when you combine a background in neurobiology with a serendipitous introduction to pharmacovigilance? Join us as Sibel Guerler, Head of Strategy and Safety Evaluation at BMS, takes us on her remarkable journey, where life's unexpected turns have led to a fulfilling career in drug safety. Transitioning from managing databases and hard copies to embracing cutting-edge technologies, Sibel’s story is a testament to adaptability and the power of seizing opportunities. Her insights offer a compelling look at how passion and a supportive environment can transform a career into a calling.

Explore the highs and lows of working within large organizations like J&J, as Sibel recounts her early days of navigating complex structures and learning from seasoned mentors. From establishing an oversight group to managing diverse responsibilities in smaller markets, her experiences illuminate the intricate world of pharmacovigilance and the importance of cultivating leadership skills. The episode unfolds with her transition to Celgene, where her enthusiasm for technological innovation reshaped her professional path, showcasing the dynamic evolution of roles in safety management.

As Sibel reflects on the broader shifts in pharmacovigilance over the last two decades, we uncover the impact of pivotal FDA and EMA legislations and the pressing need for modern, agile approaches to safety. With a focus on integrating safety considerations into digital health ideation, she challenges outdated frameworks and highlights the strategic role of safety teams in the competitive landscape of drug development.